Last reviewed · How we verify
trimethoprim-sulfamethoxazole or doxycycline
trimethoprim-sulfamethoxazole or doxycycline is a Small molecule drug developed by University of Texas Southwestern Medical Center. It is currently in Phase 1 development.
At a glance
| Generic name | trimethoprim-sulfamethoxazole or doxycycline |
|---|---|
| Sponsor | University of Texas Southwestern Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial (PHASE2)
- Effects of Treatments on Atopic Dermatitis (PHASE2)
- Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2) (PHASE3)
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) (PHASE2, PHASE3)
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) (PHASE2, PHASE3)
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) (PHASE2, PHASE3)
- Comparing Oral Versus Parenteral Antimicrobial Therapy (PHASE4)
- Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- trimethoprim-sulfamethoxazole or doxycycline CI brief — competitive landscape report
- trimethoprim-sulfamethoxazole or doxycycline updates RSS · CI watch RSS
- University of Texas Southwestern Medical Center portfolio CI
Frequently asked questions about trimethoprim-sulfamethoxazole or doxycycline
What is trimethoprim-sulfamethoxazole or doxycycline?
trimethoprim-sulfamethoxazole or doxycycline is a Small molecule drug developed by University of Texas Southwestern Medical Center.
Who makes trimethoprim-sulfamethoxazole or doxycycline?
trimethoprim-sulfamethoxazole or doxycycline is developed by University of Texas Southwestern Medical Center (see full University of Texas Southwestern Medical Center pipeline at /company/university-of-texas-southwestern-medical-center).
What development phase is trimethoprim-sulfamethoxazole or doxycycline in?
trimethoprim-sulfamethoxazole or doxycycline is in Phase 1.